Heart Test Laboratories Stock Revenue
HSCS Stock | USD 5.11 0.18 3.40% |
Heart Test Laboratories fundamentals help investors to digest information that contributes to Heart Test's financial success or failures. It also enables traders to predict the movement of Heart Stock. The fundamental analysis module provides a way to measure Heart Test's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heart Test stock.
Last Reported | Projected for Next Year | ||
Total Revenue | 4.6 K | 4.4 K |
Heart | Revenue |
Heart Test Laboratories Company Revenue Analysis
Heart Test's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Heart Test Revenue | 5.15 K |
Most of Heart Test's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heart Test Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Heart
Projected quarterly revenue analysis of Heart Test Laboratories provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Heart Test match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Heart Test's stock price.
Heart Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Heart Test is extremely important. It helps to project a fair market value of Heart Stock properly, considering its historical fundamentals such as Revenue. Since Heart Test's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heart Test's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heart Test's interrelated accounts and indicators.
-0.93 | -0.91 | -0.77 | -0.93 | -0.85 | ||
-0.93 | 1.0 | 0.8 | 0.99 | 0.87 | ||
-0.91 | 1.0 | 0.76 | 0.99 | 0.83 | ||
-0.77 | 0.8 | 0.76 | 0.74 | 0.99 | ||
-0.93 | 0.99 | 0.99 | 0.74 | 0.82 | ||
-0.85 | 0.87 | 0.83 | 0.99 | 0.82 |
Click cells to compare fundamentals
Heart Revenue Historical Pattern
Today, most investors in Heart Test Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Heart Test's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Heart Test revenue as a starting point in their analysis.
Heart Test Revenue |
Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Heart Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Heart Test Laboratories reported 5.15 K of revenue. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Heart Test Laboratories is rated # 2 in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 2.54 Million. Heart Test adds roughly 5,150 in revenue claiming only tiny portion of equities under Health Care industry.Heart Test ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Heart Test's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Heart Test's managers, analysts, and investors.Environmental | Governance | Social |
Heart Test Institutional Holders
Institutional Holdings refers to the ownership stake in Heart Test that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Heart Test's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Heart Test's value.Shares | Goldman Sachs Group Inc | 2024-03-31 | 45.8 K | Geode Capital Management, Llc | 2024-03-31 | 42.3 K | Xtx Topco Ltd | 2024-03-31 | 24.3 K | Accurate Wealth Management, Llc | 2024-03-31 | 20.4 K | Alphastar Insurance Group Ltd | 2024-03-31 | 20 K | Chapin Davis Inc | 2024-03-31 | 15 K | Cubist Systematic Strategies, Llc | 2024-03-31 | 14.1 K | Wells Fargo & Co | 2024-03-31 | 453 | Jpmorgan Chase & Co | 2024-03-31 | 10.0 | Vanguard Group Inc | 2024-03-31 | 191.5 K | Tradition Wealth Management Llc | 2024-03-31 | 180.5 K |
Heart Fundamentals
Return On Equity | -1.53 | ||||
Return On Asset | -0.53 | ||||
Operating Margin | (103.77) % | ||||
Current Valuation | (2.55 M) | ||||
Shares Outstanding | 655.62 K | ||||
Shares Owned By Insiders | 16.00 % | ||||
Shares Owned By Institutions | 2.37 % | ||||
Number Of Shares Shorted | 37.58 K | ||||
Price To Book | 0.81 X | ||||
Price To Sales | 377.16 X | ||||
Revenue | 5.15 K | ||||
Gross Profit | 2.35 K | ||||
EBITDA | (6.08 M) | ||||
Net Income | (6.35 M) | ||||
Cash And Equivalents | 4.27 M | ||||
Cash Per Share | 0.52 X | ||||
Total Debt | 1.57 M | ||||
Debt To Equity | 0.41 % | ||||
Current Ratio | 3.53 X | ||||
Book Value Per Share | 13.57 X | ||||
Cash Flow From Operations | (5.77 M) | ||||
Short Ratio | 0.10 X | ||||
Earnings Per Share | (35.00) X | ||||
Target Price | 67.5 | ||||
Number Of Employees | 12 | ||||
Beta | 3.16 | ||||
Market Capitalization | 3.47 M | ||||
Total Asset | 3.29 M | ||||
Retained Earnings | (60.76 M) | ||||
Working Capital | 863.69 K | ||||
Net Asset | 3.29 M |
About Heart Test Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heart Test Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heart Test using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heart Test Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Heart Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Heart Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will appreciate offsetting losses from the drop in the long position's value.Moving together with Heart Stock
Moving against Heart Stock
0.92 | ALHC | Alignment Healthcare LLC | PairCorr |
0.87 | ELDN | Eledon Pharmaceuticals Earnings Call Tomorrow | PairCorr |
0.69 | ALC | Alcon AG | PairCorr |
0.69 | ICUI | ICU Medical | PairCorr |
0.65 | RMD | ResMed Inc Financial Report 1st of August 2024 | PairCorr |
The ability to find closely correlated positions to Heart Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Heart Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Heart Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Heart Test Laboratories to buy it.
The correlation of Heart Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Heart Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Heart Test Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Heart Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.